Higher Prevalence of TDP-43 Proteinopathy in Cognitively Normal Asians: A Clinicopathological Study on a Multiethnic Sample

dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorNASCIMENTO, Camila
dc.contributor.authorSUEMOTO, Claudia K.
dc.contributor.authorRODRIGUEZ, Roberta D.
dc.contributor.authorALHO, Ana Tereza Di Lorenzo
dc.contributor.authorLEITE, Renata P.
dc.contributor.authorFARFEL, Jose Marcelo
dc.contributor.authorPASQUALUCCI, Carlos Augusto Goncalves
dc.contributor.authorJACOB-FILHO, Wilson
dc.contributor.authorGRINBERG, Lea T.
dc.date.accessioned2016-07-18T11:40:51Z
dc.date.available2016-07-18T11:40:51Z
dc.date.issued2016
dc.description.abstractTransactive response DNA binding protein 43 (TDP-43) proteinopathy is the major hallmark of frontotemporal lobar degeneration and amyotrophic lateral sclerosis. It is also present in a subset of Alzheimer's disease cases. Recently, few reports showed TDP-43 changes in cognitively normal elderly. In Caucasians, TDP-43 proteinopathy independently correlate with cognitive decline. However, it is challenging to establish direct links between cognitive and/or neuropsychiatric symptoms and protein inclusions in neurodegenerative diseases because individual cognitive reserves modify the threshold for clinical disease expression. Cognitive reserve is influenced by demographic, environmental and genetic factors. We investigated the relationships between demographic, clinical and neuropathological variables and TDP-43 proteinopathy in a large multiethnic sample of cognitively normal elderly. TDP-43 proteinopathy was identified in 10.5%, independently associated with older age (P=0.03) and Asian ethnicity (P=0.002). Asians showed a higher prevalence of TDP-43 proteinopathy than Caucasians, even after adjustment for sex, age, Braak stage and schooling (odds ratio=3.50, confidence interval 1.41-8.69, P=0.007). These findings suggested that Asian older adults may be protected from the clinical manifestation of brain TDP-43 proteinopathy. Future studies are needed to identify possible race-related protective factors against clinical expression of TDP-43 proteinopathies.
dc.description.indexMEDLINE
dc.description.sponsorshipSao Paulo Research Foundation
dc.description.sponsorshipFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/19833-7, 2012/07526-5, 2010/06521-4]
dc.description.sponsorshipCAPES [99999.012331/2013-09]
dc.description.sponsorshipinstitutional NIH grants [P50AG023501, P01AG019724, R01 AG040311]
dc.identifier.citationBRAIN PATHOLOGY, v.26, n.2, p.177-185, 2016
dc.identifier.doi10.1111/bpa.12296
dc.identifier.eissn1750-3639
dc.identifier.issn1015-6305
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/14140
dc.language.isoeng
dc.publisherWILEY-BLACKWELL
dc.relation.ispartofBrain Pathology
dc.rightsrestrictedAccess
dc.rights.holderCopyright WILEY-BLACKWELL
dc.subjectAsian
dc.subjectautopsy
dc.subjectcognitively normal elderly
dc.subjectdementia
dc.subjectpostmortem
dc.subjectrace
dc.subjectTDP-43 proteinopathy
dc.subject.otherfrontotemporal lobar degeneration
dc.subject.otheramyotrophic-lateral-sclerosis
dc.subject.otheralzheimers-disease
dc.subject.otherhippocampal sclerosis
dc.subject.otherargyrophilic grains
dc.subject.otherneuropsychiatric inventory
dc.subject.othercautionary note
dc.subject.otherlewy bodies
dc.subject.otherdementia
dc.subject.otherpathology
dc.subject.wosClinical Neurology
dc.subject.wosNeurosciences
dc.subject.wosPathology
dc.titleHigher Prevalence of TDP-43 Proteinopathy in Cognitively Normal Asians: A Clinicopathological Study on a Multiethnic Sample
dc.typearticle
dc.type.categoryoriginal article
dc.type.versionpublishedVersion
dspace.entity.typePublication
hcfmusp.citation.scopus24
hcfmusp.contributor.author-fmusphcCAMILA NASCIMENTO MANTELLI
hcfmusp.contributor.author-fmusphcCLAUDIA KIMIE SUEMOTO
hcfmusp.contributor.author-fmusphcROBERTA DIEHL RODRIGUEZ
hcfmusp.contributor.author-fmusphcANA TEREZA DI LORENZO ALHO
hcfmusp.contributor.author-fmusphcRENATA ELAINE PARAIZO LEITE
hcfmusp.contributor.author-fmusphcJOSE MARCELO FARFEL
hcfmusp.contributor.author-fmusphcCARLOS AUGUSTO GONCALVES PASQUALUCCI
hcfmusp.contributor.author-fmusphcWILSON JACOB FILHO
hcfmusp.contributor.author-fmusphcLEA TENENHOLZ GRINBERG
hcfmusp.description.beginpage177
hcfmusp.description.endpage185
hcfmusp.description.issue2
hcfmusp.description.volume26
hcfmusp.origemWOS
hcfmusp.origem.pubmed26260327
hcfmusp.origem.scopus2-s2.0-84941710565
hcfmusp.origem.wosWOS:000373130500004
hcfmusp.publisher.cityHOBOKEN
hcfmusp.publisher.countryUSA
hcfmusp.relation.referenceNelson PT, 2009, J NEUROPATH EXP NEUR, V68, P1, DOI 10.1097/NEN.0b013e3181919a48
hcfmusp.relation.referenceCairns NJ, 2007, ACTA NEUROPATHOL, V114, P5, DOI 10.1007/s00401-007-0237-2
hcfmusp.relation.referenceGrinberg LT, 2013, CLINICS, V68, P1140, DOI 10.6061/clinics/2013(08)13
hcfmusp.relation.referenceCairns NJ, 2007, AM J PATHOL, V171, P227, DOI 10.2353/ajpath.2007.070182
hcfmusp.relation.referenceMcKeith IG, 1996, NEUROLOGY, V47, P1113
hcfmusp.relation.referenceBrettschneider J, 2013, ANN NEUROL, V74, P20, DOI 10.1002/ana.23937
hcfmusp.relation.referenceProbst A, 2007, ACTA NEUROPATHOL, V114, P335, DOI 10.1007/s00401-007-0262-1
hcfmusp.relation.referenceAndrade-Moraes CH, 2013, BRAIN, V136, P3738, DOI 10.1093/brain/awt273
hcfmusp.relation.referenceAdler CH, 2010, MOVEMENT DISORD, V25, P642, DOI 10.1002/mds.22971
hcfmusp.relation.referenceBOURAS C, 1994, CEREB CORTEX, V4, P138, DOI 10.1093/cercor/4.2.138
hcfmusp.relation.referenceMcKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307
hcfmusp.relation.referenceLagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137
hcfmusp.relation.referenceHu WT, 2008, ACTA NEUROPATHOL, V116, P215, DOI 10.1007/s00401-008-0400-4
hcfmusp.relation.referenceKlos KJ, 2006, NEUROLOGY, V66, P1100, DOI 10.1212/01.wnl.0000204179.88955.fa
hcfmusp.relation.referenceFarfel JM, 2013, NEUROLOGY, V81, P650, DOI 10.1212/WNL.0b013e3182a08f1b
hcfmusp.relation.referenceKovacs GG, 2013, ACTA NEUROPATHOL, V126, P365, DOI 10.1007/s00401-013-1157-y
hcfmusp.relation.referenceFroehlich TE, 2001, J AM GERIATR SOC, V49, P477
hcfmusp.relation.referenceMORRIS JC, 1993, NEUROLOGY, V43, P2412
hcfmusp.relation.referenceMeguro K, 2001, INT J GERIATR PSYCH, V16, P775, DOI 10.1002/gps.430.abs
hcfmusp.relation.referenceUchino A, 2014, BRAIN PATHOL, V24, P65
hcfmusp.relation.referenceMiles TP, 2001, J AM GERIATR SOC, V49, P490, DOI 10.1046/j.1532-5415.2001.49098.x
hcfmusp.relation.referenceNag S, 2015, ANN NEUROL, V77, P942, DOI 10.1002/ana.24388
hcfmusp.relation.referenceArnold SJ, 2013, ACTA NEUROPATHOL, V126, P51, DOI 10.1007/s00401-013-1110-0
hcfmusp.relation.referenceGrinberg Lea Tenenholz, 2007, Cell and Tissue Banking, V8, P151, DOI 10.1007/s10561-006-9022-z
hcfmusp.relation.referenceNelson PT, 2014, ACTA NEUROPATHOL, V127, P825, DOI 10.1007/s00401-014-1282-2
hcfmusp.relation.referenceJORM AF, 1994, PSYCHOL MED, V24, P145
hcfmusp.relation.referenceArai T, 2009, ACTA NEUROPATHOL, V117, P125, DOI 10.1007/s00401-008-0480-1
hcfmusp.relation.referenceGeser F, 2010, ARCH NEUROL-CHICAGO, V67, P1238, DOI 10.1001/archneurol.2010.254
hcfmusp.relation.referenceCaselli RJ, 2010, NEUROSCI LETT, V473, P168, DOI 10.1016/j.neulet.2010.02.016
hcfmusp.relation.referenceDICKSON DW, 1992, NEUROBIOL AGING, V13, P179, DOI 10.1016/0197-4580(92)90027-U
hcfmusp.relation.referenceBraak H, 1997, NEUROBIOL AGING, V18, P351, DOI 10.1016/S0197-4580(97)00056-0
hcfmusp.relation.referenceMackenzie IRA, 2010, ACTA NEUROPATHOL, V119, P1, DOI 10.1007/s00401-009-0612-2
hcfmusp.relation.referenceAmador-Ortiz C, 2007, ANN NEUROL, V61, P435, DOI 10.1002/ana.21154
hcfmusp.relation.referenceCUMMINGS JL, 1994, NEUROLOGY, V44, P2308
hcfmusp.relation.referenceGeser F, 2009, ARCH NEUROL-CHICAGO, V66, P180, DOI 10.1001/archneurol.2008.558
hcfmusp.relation.referenceIkejima C, 2009, STROKE, V40, P2709, DOI 10.1161/STROKEAHA.108.542308
hcfmusp.relation.referenceCronin S, 2007, NEUROLOGY, V68, P1002, DOI 10.1212/01.wnl.0000258551.96893.6f
hcfmusp.relation.referenceMORRIS JC, 1993, NEUROLOGY, V43, P2457
hcfmusp.relation.referenceSabbagh MN, 2009, ALZ DIS ASSOC DIS, V23, P229, DOI 10.1097/WAD.0b013e318199d833
hcfmusp.relation.referenceMontine TJ, 2012, ACTA NEUROPATHOL, V123, P1, DOI 10.1007/s00401-011-0910-3
hcfmusp.relation.referenceJosephs KA, 2008, NEUROBIOL AGING, V29, P566, DOI 10.1016/j.neurobiolaging.2006.10.032
hcfmusp.relation.referenceWilson AC, 2011, INT J CLIN EXP PATHO, V4, P147
hcfmusp.relation.referenceStefanits H, 2012, ACTA NEUROPATHOL, V123, P449, DOI 10.1007/s00401-011-0936-6
hcfmusp.relation.referenceNeumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108
hcfmusp.relation.referenceJosephs KA, 2014, ACTA NEUROPATHOL, V127, P441, DOI 10.1007/s00401-013-1211-9
hcfmusp.relation.referenceRauramaa T, 2013, J NEUROPATH EXP NEUR, V72, P452, DOI 10.1097/NEN.0b013e318292492a
hcfmusp.relation.referenceBuratti E, 2010, RNA BIOL, V7, P420
hcfmusp.relation.referenceBennett DA, 2003, NEUROLOGY, V60, P1909
hcfmusp.relation.referenceWaite L, 1999, ALZ DIS ASSOC DIS, V13, P34, DOI 10.1097/00002093-199903000-00005
hcfmusp.relation.referenceSchlesinger D, 2013, MOL PSYCHIATR, V18, P79, DOI 10.1038/mp.2011.136
hcfmusp.relation.referenceBRAAK H, 1991, ACTA NEUROPATHOL, V82, P239
hcfmusp.relation.referenceCardoso M A, 1997, J Epidemiol, V7, P198
hcfmusp.relation.referenceCummings JL, 1997, NEUROLOGY, V48, pS10
hcfmusp.relation.referenceCummings Jeffrey L, 2005, Rev Neurol Dis, V2, P80
hcfmusp.relation.referenceFerretti REL, 2010, DEMENT NEUROPSYCHOL, V4, P138
hcfmusp.relation.referenceGrinberg Lea Tenenholz, 2011, Front Neurol, V2, P42, DOI 10.3389/fneur.2011.00042
hcfmusp.relation.referenceIBGE, 2010, EST PESQ INF DEM SOC
hcfmusp.relation.referenceKing A, 2015, J NEURAL TRANSM, V122, P1499, DOI 10.1007/s00702-015-1410-8
hcfmusp.relation.referenceLipson J G, 1996, Reflections, V22, P9
hcfmusp.relation.referenceWilson RS, 2013, JAMA NEUROL, V70, P1418, DOI 10.1001/jamaneurol.2013.3961
hcfmusp.scopus.lastupdate2024-05-17
relation.isAuthorOfPublication633f68d6-8adc-4c97-b24f-872398681123
relation.isAuthorOfPublicationf2cec589-a4ad-4b49-a515-19f8c359b34b
relation.isAuthorOfPublication97768a23-38ef-4f89-ba20-bd6286dfa0ee
relation.isAuthorOfPublication13622e60-22e7-4f34-9d7e-d582dd444979
relation.isAuthorOfPublication6970f34a-880a-40a0-b105-865f92d86c59
relation.isAuthorOfPublication52be23e2-dbd1-4f0e-8ad4-827de93433ba
relation.isAuthorOfPublication72f17805-b816-4624-98ba-73ed2144f830
relation.isAuthorOfPublicationc4bb26d2-ceff-4ef9-a58e-a946ddba9bd6
relation.isAuthorOfPublicationa80830d0-87fe-47a0-96ab-5f4b1f49948f
relation.isAuthorOfPublication.latestForDiscovery633f68d6-8adc-4c97-b24f-872398681123
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
art_NASCIMENTO_Higher_Prevalence_of_TDP43_Proteinopathy_in_Cognitively_Normal_2016.PDF
Tamanho:
321.96 KB
Formato:
Adobe Portable Document Format
Descrição:
publishedVersion (English)